RLMD Stock Analysis: Buy, Sell, or Hold?
RLMD - Relmada Therapeutics, Inc. Common Stock
$6.99
-0.11 (-1.55%)
▼
5d:
+7.04%
30d:
+46.54%
90d:
+44.72%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
RLMD is down 5.4% this week, but smart money is accumulating calls. Top strike: $7.5 2026-05-15 with 512 OI. Call ratio: 100% View Scanner →
Strength: 7.7/10
Get Alerted When RLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RLMD is currently trading at $6.99, which is considered extended relative to its 30-day fair value range of $4.80 to $6.75.
Technical Outlook: Technically, RLMD is in a uptrend. Immediate support is located at $5.68, while resistance sits at $7.37.
Market Sentiment: RLMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $5.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RLMD is in a uptrend. Immediate support is located at $5.68, while resistance sits at $7.37.
Market Sentiment: RLMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $5.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$4.80 -
$6.75
Company Quality Score
65/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Trading 21.3% above Wall St target ($5.50)
Fair Price Analysis
30-Day Fair Range
$4.80 -
$6.75
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$5.68
Resistance Level
$7.37
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.42
Wall Street Target
$5.50
(-21.3%)
Share & Embed Analysis
Last updated: April 05, 2026 1:30 PM ET
Data refreshes hourly during market hours. Next update: 2:30 PM
Data refreshes hourly during market hours. Next update: 2:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLMD showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Maged Shenouda
BUY
11665 shares
2025-12-15
Chuck Ence
BUY
136000 shares
2025-11-05
Maged Shenouda
BUY
500000 shares
2025-11-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 63 BUY |
